These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23880739)
1. Should histologic variants alter definitive treatment of bladder cancer? Willis DL; Porten SP; Kamat AM Curr Opin Urol; 2013 Sep; 23(5):435-43. PubMed ID: 23880739 [TBL] [Abstract][Full Text] [Related]
2. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Black PC; Brown GA; Dinney CP Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107 [TBL] [Abstract][Full Text] [Related]
3. Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer. Porten SP; Willis D; Kamat AM Curr Opin Urol; 2014 Sep; 24(5):517-23. PubMed ID: 24921905 [TBL] [Abstract][Full Text] [Related]
4. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101 [TBL] [Abstract][Full Text] [Related]
5. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. Abd El-Latif A; Watts KE; Elson P; Fergany A; Hansel DE J Urol; 2013 Apr; 189(4):1263-7. PubMed ID: 23085297 [TBL] [Abstract][Full Text] [Related]
6. Nonurothelial bladder cancer and rare variant histologies. Willis D; Kamat AM Hematol Oncol Clin North Am; 2015 Apr; 29(2):237-52, viii. PubMed ID: 25836932 [TBL] [Abstract][Full Text] [Related]
7. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
8. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer? Linder BJ; Boorjian SA; Cheville JC; Sukov WR; Thapa P; Tarrell RF; Frank I J Urol; 2013 Nov; 190(5):1692-6. PubMed ID: 23707452 [TBL] [Abstract][Full Text] [Related]
9. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126 [TBL] [Abstract][Full Text] [Related]
10. Urothelial carcinoma of the bladder and the upper tract: disparate twins. Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150 [TBL] [Abstract][Full Text] [Related]
11. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493 [TBL] [Abstract][Full Text] [Related]
12. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Shanks JH; Iczkowski KA Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589 [TBL] [Abstract][Full Text] [Related]
14. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903 [TBL] [Abstract][Full Text] [Related]
15. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Coblentz TR; Mills SE; Theodorescu D Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928 [TBL] [Abstract][Full Text] [Related]
16. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811 [TBL] [Abstract][Full Text] [Related]
18. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317 [TBL] [Abstract][Full Text] [Related]
19. Treatment of muscle-invasive bladder cancer: progress and new challenges. Herring JC; Kamat AM Expert Rev Anticancer Ther; 2004 Dec; 4(6):1047-56. PubMed ID: 15606332 [TBL] [Abstract][Full Text] [Related]
20. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]